Literature DB >> 27725021

Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study.

E P Budgell1, D Evans, K Schnippel, P Ive, L Long, S Rosen.   

Abstract

BACKGROUND: Despite the large number of tuberculosis (TB) patients treated in South Africa (SA), there are few descriptions in the published literature of drug-susceptible TB patient characteristics, mode of diagnosis or treatment outcomes in routine public sector treatment programmes.
OBJECTIVE: To enhance the evidence base for public sector TB treatment service delivery, we reported the characteristics of and outcomes for a retrospective cohort of adult TB patients at public sector clinics in the Johannesburg Metropolitan Municipality (JHB), SA.
METHODS: We collected medical record data for a retrospective cohort of adult (≥18 years) TB patients registered between 1 April 2011 and 31 March 2012 at three public sector clinics in JHB. Data were abstracted from National TB Programme clinic cards and the TB case registers routinely maintained at study sites. We report patient characteristics, mode of diagnosis, mode of treatment supervision, treatment characteristics, HIV status and treatment outcomes for this cohort.
RESULTS: A total of 544 patients were enrolled in the cohort. Most (86%) were new TB cases, 81% had pulmonary TB, 58% were smear-positive at treatment initiation and 71% were HIV co-infected. Among 495 patients with treatment outcomes reported, 80% (n=394) had successful outcomes, 11% (n=55) were lost to follow-up, 8% (n=40) died and 1% (n=6) failed treatment.
CONCLUSIONS: Primary healthcare clinics in JHB are achieving relatively high rates of success in treating drug-susceptible TB. Missing laboratory results were common, including follow-up smears, cultures and drug susceptibility tests, making it difficult to assess adherence to guidelines and leaving scope for substantial improvements in record-keeping at the clinics involved.

Entities:  

Year:  2016        PMID: 27725021     DOI: 10.7196/SAMJ.2016.v106i10.10745

Source DB:  PubMed          Journal:  S Afr Med J


  8 in total

1.  Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness Analysis.

Authors:  Krishna P Reddy; C Robert Horsburgh; Robin Wood; Naomi F Fields; Michael P Girouard; Sydney Costantini; Taige Hou; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Ann Am Thorac Soc       Date:  2020-02

2.  Treatment outcomes of Gene Xpert positive tuberculosis patients in KwaMashu Community Health Centre, KwaZulu-Natal, South Africa: A retrospective review.

Authors:  Sarusha Pillay; Nombulelo P Magula
Journal:  S Afr J Infect Dis       Date:  2021-04-07

3.  The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis.

Authors:  K Rees; N Muditambi; M Maswanganyi; J Railton; J A McIntyre; H E Struthers; P B Fourie; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-12-06       Impact factor: 4.434

4.  Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa.

Authors:  Ingrid V Bassett; Leah S Forman; Sabina Govere; Hilary Thulare; Simone C Frank; Bright Mhlongo; Elena Losina
Journal:  BMC Infect Dis       Date:  2019-02-04       Impact factor: 3.090

5.  Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.

Authors:  Kaitlyn M Berry; Carly A Rodriguez; Rebecca H Berhanu; Nazir Ismail; Lindiwe Mvusi; Lawrence Long; Denise Evans
Journal:  BMC Public Health       Date:  2019-07-22       Impact factor: 3.295

6.  Protocol for systematic review and meta-analysis of treatment success rate among adult patients with tuberculosis in sub-Saharan Africa.

Authors:  Jonathan Izudi; Daniel Semakula; Richard Sennono; Imelda K Tamwesigire; Francis Bajunirwe
Journal:  BMJ Open       Date:  2018-12-28       Impact factor: 2.692

7.  Treatment success rate among adult pulmonary tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Jonathan Izudi; Daniel Semakula; Richard Sennono; Imelda K Tamwesigire; Francis Bajunirwe
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

8.  Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.

Authors:  Ninfa Marlen Chaves Torres; Jecxy Julieth Quijano Rodríguez; Pablo Sebastián Porras Andrade; María Belen Arriaga; Eduardo Martins Netto
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.